MAPT and Alzheimer disease: To investigate the potential role of TYK2 in disease progression and tau accumulation, we measured the total TYK2, the active form of TYK2 (pTYK2 at Tyr292)40, and pathological tau species in brain tissue samples from patients with AD (Supplementary Table 1) using IB analysis.